This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
£34.07
Share price
0.00%
Change (1 day)
115.05%
Change (1 year)
Categories
Albireo Pharma (ALBO) - P/B ratio
P/B ratio as of March 2025 : 9.15
According to Albireo Pharma's latest financial reports the company has a price-to-book ratio of 15.9587.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Albireo Pharma - P/B ratio (from 2007 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 4.47 | 74.68% |
| 2021-12-31 | 2.56 | -35.29% |
| 2020-12-31 | 3.95 | 13.68% |
| 2019-12-31 | 3.48 | 45.3% |
| 2018-12-31 | 2.39 | -31.43% |
| 2017-12-31 | 3.49 | -17.26% |
| 2016-12-31 | 4.22 | 599.94% |
| 2015-12-31 | 0.6029 | -63.5% |
| 2014-12-31 | 1.65 | 4.62% |
| 2013-12-31 | 1.58 | 32.22% |
| 2012-12-31 | 1.19 | 69.12% |
| 2011-12-31 | 0.7061 | -70.46% |
| 2010-12-31 | 2.39 | -5.87% |
| 2009-12-31 | 2.54 | 77.44% |
| 2008-12-31 | 1.43 | -79.07% |
| 2007-12-31 | 6.84 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 2.29 | -74.94% | 🇺🇸 USA |